Orchestra BioMed Holdings (OBIO) Inventory Average (2023 - 2026)
Orchestra BioMed Holdings (OBIO) posted quarterly Inventory Average of $293500.0 for Q1 2026, up 90.58% year-over-year from $154000.0 in Q1 2025, and down 13.04% quarter-over-quarter from $337500.0 in Q4 2025.
Powered by 
Analysis
Orchestra BioMed Holdings (OBIO) Inventory Average (2023 - 2026) Analysis & Trends
Orchestra BioMed Holdings (OBIO) has reported Inventory Average for 4 consecutive years, with $293500.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory Average rose 90.58% year-over-year to $293500.0; the TTM figure through Mar 2026 stood at $293500.0 (up 90.58% YoY), while the FY2025 annual figure was $241500.0, up 51.41% from the prior year.
- Inventory Average slipped to $293500.0 in Q1 2026 per OBIO's latest filing, from $337500.0 in the prior quarter.
- Across five years, Inventory Average topped out at $337500.0 in Q4 2025 and bottomed at $92500.0 in Q2 2024.
- Historically, Inventory Average has averaged $196653.8 across 4 years, with a median of $160000.0 in 2025.
- Annual changes were most pronounced in 2024 — Inventory Average plunged 54.88% — and 2026, when it surged 90.58%.
- Orchestra BioMed Holdings' Inventory Average stood at $141500.0 in 2023, then soared by 43.82% to $203500.0 in 2024, then jumped by 65.85% to $337500.0 in 2025, then declined by 13.04% to $293500.0 in 2026.
- Business Quant data shows OBIO's Inventory Average at $293500.0 in Q1 2026, $337500.0 in Q4 2025, and $275000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 213.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 707.10 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 90.57 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Orchestra BioMed Holdings | 322.25 Mn | 127.72 Mn | 63,000.00 | 263,500.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 263,500.00 |
| Mar 31, 2026 | 293,500.00 |
| Dec 31, 2025 | 337,500.00 |
| Sep 30, 2025 | 275,000.00 |
| Jun 30, 2025 | 160,000.00 |
| Mar 31, 2025 | 154,000.00 |
| Dec 31, 2024 | 203,500.00 |
| Sep 30, 2024 | 152,000.00 |
| Jun 30, 2024 | 92,500.00 |
| Mar 31, 2024 | 130,500.00 |
| Dec 31, 2023 | 141,500.00 |
| Sep 30, 2023 | 157,500.00 |
| Jun 30, 2023 | 205,000.00 |
| Mar 31, 2023 | 254,000.00 |